Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
about
A stochastic model of oncogene expression and the relevance of this model to cancer therapy.Comprehensive evaluation of fusion transcript detection algorithms and a meta-caller to combine top performing methods in paired-end RNA-seq data.Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment.Evaluation of a new flow cytometry based method for detection of BCR-ABL1 fusion protein in chronic myeloid leukemia.Development and targeted use of nilotinib in chronic myeloid leukemia.The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemiaMolecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction.Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disordersTherapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).Management of Bcr-Abl-positive leukemias with dasatinib.A rare e14a3 (b3a3) BCR-ABL fusion transcript in chronic myeloid leukemia: diagnostic challenges in clinical laboratory practice.1,3-Butadiene: II. Genotoxicity profile.1,3-Butadiene: III. Assessing carcinogenic modes of action.ABL1 fusion genes in hematological malignancies: a review.Polycomb group proteins in hematopoietic stem cell aging and malignancies.Dasatinib for the treatment of chronic myeloid leukemia.Expression of the p210BCR-ABL oncoprotein drives centrosomal hypertrophy and clonal evolution in human U937 cells.Characterization of gene rearrangements leading to activation of MDR-1.Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue.How to detect the rare BCR-ABL (e14a3) transcript: A case report and literature review.Transcriptional suppression of BACH2 by the Bcr-Abl oncoprotein is mediated by PAX5.Impact of Chromosomal Rearrangement upon DNA Methylation Patterns in Leukemia.
P2860
Q25256645-C80F1B42-90E5-4F25-A283-32577FCA3C9CQ31026263-780789D2-A81F-4704-9F78-A26BB55440E8Q33513975-D76A0E0C-D252-4017-BD20-548FA81E6F95Q33889952-6AD5F135-674E-4B7B-B61E-DA26EB7B454DQ34613968-C87FE67D-8F5F-4B9E-A4C4-2C7548EA544EQ35547514-8EFB1536-605D-42BB-9AC5-A89C9CC68C9FQ35782919-B73C8853-C9C5-4242-B939-FD3A1B8D90CBQ36374813-331695DB-E970-42A1-92C0-6DF57CDE6097Q36822880-36A728F5-F249-44E5-A7B6-2C8ABF23DD61Q37004660-1AB2155C-07FC-4FA7-92AC-B38C6EF807FAQ37261884-2071B10B-ECDB-400E-A42E-B0DE5FF91F92Q37792078-0418088E-2C34-4DDE-B15E-786FA7EF5337Q37792081-09DECF49-0638-46BF-B3E4-B8B02385FD5BQ37857340-664F61F6-58A1-4DC4-B7F9-3A20E288CA98Q37869366-9FBB429C-CF9F-4D74-AAB8-6ACE36BB3EC6Q39739850-0A34D9EE-9138-4282-A5DA-4C66B277FC79Q40114134-8613E07A-DF46-4D23-91AF-F3EADCE7356DQ40234896-CC3C3206-44B1-410B-BF3C-B2914F02A782Q41694275-C350CFBB-79CB-45EA-B106-20957572D802Q44275292-EF8524CD-95D1-499F-81FF-15C16B31D42AQ47308589-4296303F-8266-4F7D-B91C-3993EE450AE1Q52761621-62BDCC11-57A9-4920-99FD-680949E33199
P2860
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
@ast
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
@en
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
@nl
type
label
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
@ast
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
@en
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
@nl
prefLabel
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
@ast
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
@en
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
@nl
P356
P1433
P1476
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
@en
P2093
David J Barnes
Junia V Melo
P304
P356
10.1159/000065655
P577
2002-01-01T00:00:00Z